Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 37-48 of 60
» View latimes.com items only
    Jun 6, 2011 |Story| WSBT-TV
  1. Cancer-fighting pill shows promise in battle against melanoma

    <span style="font-size: small;">MISHAWAKA--- Doctors say a cancer-fighting pill shows promising signs in the fight against melanoma -- the most deadly form of skin cancer. </span>
    MISHAWAKA--- Doctors say a cancer-fighting pill shows promising signs in the fight against melanoma -- the most deadly form of skin cancer. A local oncologist says drug is not a cure, but it shrank tumors and patients who used the drug lived longer....

    Tags: Drugs and Medicines, Skin Cancer, Health Treatments, Skin, Cancer

  2. Jun 5, 2011 |Story| Reuters
  3. Jun 5, 2011 |Story| KCPQ-LTV
  4. Two new drugs extend survival for Melanoma patients

    For the first time, patients with the deadliest form of skin cancer have two new treatment options that prolong survival, according to new research presented at a cancer conference in Chicago on Sunday. One drug specifically targets a mutated gene that...

    Tags: Skin Cancer, Cancer, Medical Research, Science and Technology, Human Body

  5. Feb 18, 2011 | Orlando Sentinel
  6. Obama meets tech leaders for dinner

    Tech for the Rest of Us - Orlando Sentinel
    It was an impressive list of names who attended a dinner Thursday night with President Obama. The Wall Street Journal had a picture of everyone, including Apple’s Steve Jobs who is on medical leave, raising their glasses.  “The president...
  7. Jun 30, 2010 |Story| Health Portal
  8. Avastin may cause kidney damage

    A widely prescribed cancer drug noted for its ability to choke off blood vessels that help tumors grow can cause significant kidney damage in some patients, a team of Long Island scientists has found.
    McClatchy Tribune
    A widely prescribed cancer drug noted for its ability to choke off blood vessels that help tumors grow can cause significant kidney damage in some patients, a team of Long Island scientists has found. Kidney problems are the second serious condition...

    Tags: Memorial Sloan-Kettering Cancer Center, Cancer, Stony Brook University, Science and Technology, Tumors

  9. Jul 21, 2010 |Story| Los Angeles Times
  10. Avastin rejected for breast cancer

    A Food and Drug Administration advisory committee Tuesday recommended that the agency withdraw its marketing approval of the blockbuster cancer drug Avastin for treating breast cancer, concluding that new trials showed no apparent benefit from the drug.
    Los Angeles Times
    A Food and Drug Administration advisory committee Tuesday recommended that the agency withdraw its marketing approval of the blockbuster cancer drug Avastin for treating breast cancer, concluding that new trials showed no apparent benefit from the drug....

    Tags: Colon, Drugs and Medicines, Crime, Law and Justice, Marketing, Health and Medical Professionals

  11. Sep 2, 2010 |Story| Chicago Tribune
  12. FDA urged to pull diet drug from market

    The prescription diet drug sibutramine, sold under the brand name Meridia, should be taken off the market because it raises the risk of heart attacks and strokes in some patients, the editor of the New England Journal of Medicine said Wednesday.
    Tribune Newspapers
    The prescription diet drug sibutramine, sold under the brand name Meridia, should be taken off the market because it raises the risk of heart attacks and strokes in some patients, the editor of the New England Journal of Medicine said Wednesday. Those...

    Tags: Overweight, Weight, Health and Medical Professionals, History, Obesity

  13. Jul 20, 2010 |Story| Associated Press
  14. FDA panel: Roche drug should lose approval for breast cancer after disappointing studies

    GAITHERSBURG (AP) &#8212; A panel of cancer experts said Tuesday that the government should remove its endorsement of Roche's drug Avastin for breast cancer, after follow-up studies failed to show benefits for patients.
    AP BUSINESS WRITER
    GAITHERSBURG (AP) — A panel of cancer experts said Tuesday that the government should remove its endorsement of Roche's drug Avastin for breast cancer, after follow-up studies failed to show benefits for patients. A Food and Drug Administration...

    Tags: Chiropractors, Colon, Health and Medical Professionals, Health Treatments, Breast Cancer

  15. Aug 5, 2010 |Story| Associated Press
  16. Task Force Urges More Osteoporosis Screening

    Routine screening for osteoporosis should include all younger postmenopausal women who have at least the same chance of a bone break as an older woman, a government task force said.
    Associated Press
    Routine screening for osteoporosis should include all younger postmenopausal women who have at least the same chance of a bone break as an older woman, a government task force said. Also, for the first time, the group weighed whether men should be...

    Tags: Chiropractors, Internal Medicine, Drugs and Medicines, Medical Procedures and Tests, Portland (Multnomah, Oregon)

  17. May 8, 2009 |Story| KSWB-LTV
  18. Women to lead two UC campuses

    FOX 5 San Diego Staff
    The University of California will have two new chancellors this fall, and both of them are women with strong credentials in science and engineering. The UC Board of Regents on Thursday approved the appointments of Susan Desmond-Hellmann as chancellor...

    Tags: Colleges and Universities, University of California, Science and Technology, University of Illinois at Urbana-Champaign, Education

  19. Oct 14, 2007 |Story| Chicago Tribune
  20. The week ahead

    Chicago Tribune
    Monday: Earnings: Citigroup Inc.; Eaton Corp.; Genentech Inc.; Mattel Inc.; Nuveen Investments Inc.; Sonic Corp.; W.W. Grainger Inc. Tuesday: September industrial production Earnings: CSX Corp.; Equity Lifestyles Properties Inc.; Forest Laboratories Inc....

    Tags: Federal Reserve, Baxter International Inc., Citrix Systems Incorporated, Nucor Corporation, Illinois Tool Works Incorporated

  21. May 27, 2007 |Story| Tribune Media Services
  22. Alcoa shares soar amid high demand, potential merger

    Tribune Media Services columnist
    Q: I'm not sure what to make of Alcoa Inc. Should I keep its shares in my portfolio? --K.G., via the Internet A: The world's largest aluminum producer is expected to turn in record revenues for the next couple of years. Global demand for aluminum is...

    Tags: Boeing Co., Economy, Business and Finance, Morningstar Incorporated, Goldman Sachs Group, Inc., Metal and Mineral

< Previous1 2 3  4  5Next >
Original site for Genentech Inc. topic gallery.
Advertisement
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Genentech Inc. Photos
Some firms seek to make "biosimilar" drugs that would p...
(April 25, 2013)
Bill would regulate &#8216;biosimilar&#8217; drugs
A sign is displayed in front of the Genentech headquart...
(December 13, 2012)
A sign is displayed in front of the Genentech headquarters July 14, 2008 in South San Francisco, California. This company relied on the popularity of its cancer drug Avastin to boost profits.
Dr. Jeffrey Bloss has joined Astellas US LLC as vice pr...
(November 28, 2012)
Dr. Jeffrey Bloss, vice president of scientific and medical affairs, Astellas US LLC